Foto del docente

Chiara Fabbri

Ricercatrice a tempo determinato tipo b) (senior)

Dipartimento di Scienze Biomediche e Neuromotorie

Settore scientifico disciplinare: MED/25 PSICHIATRIA

Pubblicazioni

Dold, Markus; Bartova, Lucie; Fugger, Gernot; Mitschek, Marleen Mm; Fabbri, Chiara; Serretti, Alessandro; Mendlewicz, Julien; Souery, Daniel; Zohar, Joseph; Montgomery, Stuart; Kasper, Siegfried, Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study, «JOURNAL OF AFFECTIVE DISORDERS», 2022, 296, pp. 485 - 492 [articolo]

Oliva V.; Fanelli G.; Kasper S.; Zohar J.; Souery D.; Montgomery S.; Albani D.; Forloni G.; Ferentinos P.; Rujescu D.; Mendlewicz J.; Kas M.J.; de Ronchi D.; Fabbri C.; Serretti A., Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts, «INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY», 2022, 37, pp. 38 - 45 [articolo]Open Access

Fabbri, Chiara; Mutz, Julian; Lewis, Cathryn M; Serretti, Alessandro, Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank, «JOURNAL OF AFFECTIVE DISORDERS», 2022, 314, pp. 281 - 292 [articolo]

Bartova, Lucie; Fugger, Gernot; Dold, Markus; Kautzky, Alexander; Swoboda, Marleen Margret Mignon; Rujescu, Dan; Zohar, Joseph; Souery, Daniel; Mendlewicz, Julien; Montgomery, Stuart; Fabbri, Chiara; Serretti, Alessandro; Kasper, Siegfried, The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder, «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2022, 25, pp. 118 - 127 [articolo]Open Access

Lippi, Matteo; Fanelli, Giuseppe; Fabbri, Chiara; De Ronchi, Diana; Serretti, Alessandro, The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?, «INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY», 2022, 37, pp. 263 - 275 [articolo]Open Access

Fanelli, Giuseppe; Mota, Nina Roth; Salas-Salvadó, Jordi; Bulló, Mònica; Fernandez-Aranda, Fernando; Camacho-Barcia, Lucía; Testa, Giulia; Jiménez-Murcia, Susana; Bertaina-Anglade, Valérie; Franke, Barbara; Poelmans, Geert; van Gils, Veerle; Jansen, Willemijn J; Vos, Stephanie J B; Wimberley, Theresa; Dalsgaard, Søren; Barta, Csaba; Serretti, Alessandro; Fabbri, Chiara; Bralten, Janita, The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review, «NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS», 2022, 143, Article number: 104927, pp. 1 - 12 [articolo]Open Access

Fugger, Gernot; Bartova, Lucie; Fabbri, Chiara; Fanelli, Giuseppe; Zanardi, Raffaella; Dold, Markus; Kautzky, Alexander; Rujescu, Dan; Souery, Daniel; Mendlewicz, Julien; Zohar, Joseph; Montgomery, Stuart; Serretti, Alessandro; Kasper, Siegfried, The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs, «JOURNAL OF AFFECTIVE DISORDERS», 2022, 312, pp. 225 - 234 [articolo]Open Access

Fugger, Gernot; Bartova, Lucie; Fabbri, Chiara; Fanelli, Giuseppe; Dold, Markus; Swoboda, Marleen Margret Mignon; Kautzky, Alexander; Zohar, Joseph; Souery, Daniel; Mendlewicz, Julien; Montgomery, Stuart; Rujescu, Dan; Serretti, Alessandro; Kasper, Siegfried, The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries, «EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE», 2022, 272, pp. 715 - 727 [articolo]Open Access

Fabbri, Chiara, An interview with Dr Chiara Fabbri: pharmacogenomics and drug repurposing for treatment-resistant depression, «PHARMACOGENOMICS», 2021, 22, pp. 1107 - 1109 [replica/breve intervento]

Bartova L.; Fugger G.; Dold M.; Swoboda M.M.M.; Zohar J.; Mendlewicz J.; Souery D.; Montgomery S.; Fabbri C.; Serretti A.; Kasper S., Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression, «JOURNAL OF PSYCHIATRIC RESEARCH», 2021, 141, pp. 167 - 175 [articolo]Open Access

Pavarin R.M.; Fioritti A.; Fabbri C.; Sanchini S.; De Ronchi D., Comparison of Mortality Rates between Italian and Foreign-born Patients with Alcohol Use Disorders, «JOURNAL OF PSYCHOACTIVE DRUGS», 2021, ahead of print, pp. 1-11 - 11 [articolo]

Fabbri C.; Kasper S.; Zohar J.; Souery D.; Montgomery S.; Albani D.; Forloni G.; Ferentinos P.; Rujescu D.; Mendlewicz J.; Serretti A.; Lewis C.M., Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression, «JOURNAL OF AFFECTIVE DISORDERS», 2021, 279, pp. 722 - 729 [articolo]Open Access

Fabbri C.; Kasper S.; Zohar J.; Souery D.; Montgomery S.; Albani D.; Forloni G.; Ferentinos P.; Rujescu D.; Mendlewicz J.; De Ronchi D.; Riva M.A.; Lewis C.M.; Serretti A., Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study, «PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY», 2021, 104, Article number: 110050, pp. 1 - 11 [articolo]

Fabbri C.; Hagenaars S.P.; John C.; Williams A.T.; Shrine N.; Moles L.; Hanscombe K.B.; Serretti A.; Shepherd D.J.; Free R.C.; Wain L.V.; Tobin M.D.; Lewis C.M., Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts, «MOLECULAR PSYCHIATRY», 2021, 26, pp. 3363 - 3373 [articolo]Open Access

Bralten J.; Mota N.R.; Klemann C.J.H.M.; De Witte W.; Laing E.; Collier D.A.; de Kluiver H.; Bauduin S.E.E.C.; Arango C.; Ayuso-Mateos J.L.; Fabbri C.; Kas M.J.; van der Wee N.; Penninx B.W.J.H.; Serretti A.; Franke B.; Poelmans G., Genetic underpinnings of sociability in the general population, «NEUROPSYCHOPHARMACOLOGY», 2021, 46, pp. 1627 - 1634 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.